First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy
ConclusionsWe are the first group to describe preschool P-OIT in a real-world multicenter setting. The treatment appears to be safe for the vast majority of patients because symptoms were generally mild and very few reactions received epinephrine; however, life-threatening reactions in a minority of patients (0.4%) can still occur.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Academia | Allergy | Allergy & Immunology | Canada Health | Children | Clinical Trials | Immunotherapy | Peanuts | Skin